Compare LFMD & NPCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LFMD | NPCT |
|---|---|---|
| Founded | 1994 | 2020 |
| Country | United States | United States |
| Employees | 384 | N/A |
| Industry | Medical/Nursing Services | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.9M | 294.2M |
| IPO Year | N/A | N/A |
| Metric | LFMD | NPCT |
|---|---|---|
| Price | $3.90 | $10.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $9.14 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 138.5K |
| Earning Date | 03-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.82% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $17.76 | N/A |
| Revenue Next Year | $17.66 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.60 | $9.77 |
| 52 Week High | $15.34 | $11.31 |
| Indicator | LFMD | NPCT |
|---|---|---|
| Relative Strength Index (RSI) | 56.18 | 35.01 |
| Support Level | $3.43 | $10.01 |
| Resistance Level | $4.20 | $10.32 |
| Average True Range (ATR) | 0.35 | 0.12 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 54.27 | 28.00 |
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to seek total return through high current income and capital appreciation, while giving special consideration to certain impact and environmental, social and governance criteria.